Takatsuki, Japan

Toshihiro Kiguchi


Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Takatsuki, JP (2007)
  • Osaka, JP (2007)

Company Filing History:


Years Active: 2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Toshihiro Kiguchi

Introduction

Toshihiro Kiguchi is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target calcium-sensing receptors. With a total of 2 patents to his name, Kiguchi's work is paving the way for advancements in therapeutic drugs.

Latest Patents

Kiguchi's latest patents focus on the development of CaSR antagonists. The first patent describes a compound represented by a specific formula, which includes a pharmaceutically acceptable salt or an optically active form. This compound exhibits calcium-sensing receptor antagonistic action and is aimed at providing a therapeutic solution for osteoporosis. The second patent similarly outlines a compound with calcium-sensitive receptor antagonistic properties, emphasizing its potential as a pharmaceutical composition for treating osteoporosis.

Career Highlights

Kiguchi is currently employed at Japan Tobacco Inc., where he continues to innovate and contribute to the field of pharmaceutical research. His work is characterized by a commitment to developing effective therapeutic drugs that address critical health issues.

Collaborations

Kiguchi collaborates with esteemed colleagues, including Yuko Shinagawa and Teruhiko Inoue. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Toshihiro Kiguchi's contributions to pharmaceutical innovations, particularly in the area of calcium-sensing receptor antagonists, highlight his role as a significant inventor in the field. His ongoing work promises to lead to important advancements in the treatment of osteoporosis and other related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…